These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 34203237)

  • 81. Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets.
    Wu L; Xie X; Liang T; Ma J; Yang L; Yang J; Li L; Xi Y; Li H; Zhang J; Chen X; Ding Y; Wu Q
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053186
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Application of Immune Checkpoint Inhibitors in Gynecological Cancers: What Do Gynecologists Need to Know before Using Immune Checkpoint Inhibitors?
    Lee SM; Lee S; Cho HW; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674491
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology.
    DiNatale RG; Hakimi AA; Chan TA
    Hum Mol Genet; 2020 Oct; 29(R2):R214-R225. PubMed ID: 33029628
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?
    Ruiz de Porras V; Pardo JC; Notario L; Etxaniz O; Font A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946818
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.
    Shaver KA; Croom-Perez TJ; Copik AJ
    Front Immunol; 2021; 12():679117. PubMed ID: 33995422
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 87.
    Zhang N; Shen J; Gou L; Cao M; Ding W; Luo P; Zhang J
    Bioengineered; 2022 May; 13(5):11577-11592. PubMed ID: 35531878
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Omics approaches in bioremediation of environmental contaminants: An integrated approach for environmental safety and sustainability.
    Sharma P; Singh SP; Iqbal HMN; Tong YW
    Environ Res; 2022 Aug; 211():113102. PubMed ID: 35300964
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Foodomics as part of the host-microbiota-exposome interplay.
    Putignani L; Dallapiccola B
    J Proteomics; 2016 Sep; 147():3-20. PubMed ID: 27130534
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Gut Microbiota and Immune Checkpoint Inhibitors-Based Immunotherapy.
    Tian M; Zhang S; Tseng Y; Shen X; Dong L; Xue R
    Anticancer Agents Med Chem; 2022; 22(7):1244-1256. PubMed ID: 34229597
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers.
    Tolba MF; Elghazaly H; Bousoik E; Elmazar MMA; Tolaney SM
    Clin Transl Oncol; 2021 Oct; 23(10):1979-1994. PubMed ID: 33871826
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Therapeutic interventions and mechanisms associated with gut microbiota-mediated modulation of immune checkpoint inhibitor responses.
    Wong MK; Barbulescu P; Coburn B; Reguera-Nuñez E
    Microbes Infect; 2021; 23(6-7):104804. PubMed ID: 33652120
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability.
    Tostes K; Siqueira AP; Reis RM; Leal LF; Arantes LMRB
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569262
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Application of Multiple Omics to Understand Postoperative Delirium Pathophysiology in Humans.
    Vasunilashorn SM; Dillon ST; Marcantonio ER; Libermann TA
    Gerontology; 2023; 69(12):1369-1384. PubMed ID: 37722373
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Novel integrative multi-omics strategies of human's biological age computation.].
    Solovev IA
    Adv Gerontol; 2024; 37(1-2):21-25. PubMed ID: 38944768
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Challenges and Perspective in Integrated Multi-Omics in Gut Microbiota Studies.
    Daliri EB; Ofosu FK; Chelliah R; Lee BH; Oh DH
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671370
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Network analyses in microbiome based on high-throughput multi-omics data.
    Liu Z; Ma A; Mathé E; Merling M; Ma Q; Liu B
    Brief Bioinform; 2021 Mar; 22(2):1639-1655. PubMed ID: 32047891
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Omics sciences and precision medicine in lung cancer.
    Micheletti C; Dhuli K; Donato K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):37-45. PubMed ID: 37994747
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours.
    Fuller-Shavel N; Krell J
    Curr Oncol Rep; 2024 Feb; 26(2):164-174. PubMed ID: 38194216
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Resistance to immune checkpoint inhibitors in gastric cancer.
    Liu K; Yuan S; Wang C; Zhu H
    Front Pharmacol; 2023; 14():1285343. PubMed ID: 38026944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.